GSK - Doublet: A Phase I Study of Pegylated Liposomal Doxorubicin (Doxil) and Weekly Intravenous Topotecan in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2008
At a glance
- Drugs Doxorubicin liposomal; Topotecan
- Indications Solid tumours
- Focus Therapeutic Use
- 26 Nov 2008 Last checked against ClinicalTrials.gov.
- 16 May 2006 Status changed from recruiting to completed.
- 22 Dec 2005 New trial record.